CorMedix
CRMD
#7002
Rank
A$0.83 B
Marketcap
A$10.51
Share price
-1.06%
Change (1 day)
-25.89%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2025 (TTM): A$0.16 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$27.13 Million, an increase over its 2023 earnings that were of -A$65.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.16 B-709.05%
2024 -A$27.13 Million-58.3%
2023 -A$65.04 Million53%
2022 -A$42.51 Million2.81%
2021 -A$41.35 Million8.32%
2020 -A$38.18 Million26.53%
2019 -A$30.17 Million-19.89%
2018 -A$37.66 Million-18.72%
2017 -A$46.33 Million34.56%
2016 -A$34.43 Million34.88%
2015 -A$25.53 Million-11.08%
2014 -A$28.71 Million124.69%
2013 -A$12.78 Million144.91%
2012 -A$5.22 Million-48.41%
2011 -A$10.12 Million-33.29%
2010 -A$15.16 Million78.42%
2009 -A$8.5 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.76 B 1,739.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$20.51 M-86.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B 54.44%๐Ÿ‡บ๐Ÿ‡ธ USA